Prevalence and Predictors of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome von Ehrmann, David A., Liljenquist, David R., Kasza, Kristen, Azziz, Ricardo, Legro, Richard S., Ghazzi, Mahmoud N.

Volltext

Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome : A multicenter, double blind, placebo-controlled trial von AZZIZ, Ricardo, EHRMANN, David, LEGRO, Richard S, WHITCOMB, Randall W, HANLEY, Rochelle, FERESHETIAN, Anita Gmerek, O'KEEFE, Mary, GHAZZI, Mahmoud N

Volltext

Effects of Race and Family History of Type 2 Diabetes on Metabolic Status of Women with Polycystic Ovary Syndrome von Ehrmann, David A., Kasza, Kristen, Azziz, Ricardo, Legro, Richard S., Ghazzi, Mahmoud N.

Volltext

Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients von KUMAR, S, BOULTON, A. J. M, BECK-NIELSEN, H, BERTHEZENE, F, MUGGEO, M, PERSSON, B, SPINAS, G. A, DONOGHUE, S, LETTIS, S, STEWART-LONG, P

Volltext

Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome von Azziz, Ricardo, Ehrmann, David A., Legro, Richard S., Fereshetian, Anita G., O’Keefe, Mary, Ghazzi, Mahmoud N.

Volltext

Troglitazone in combination with sulphonylurea improves glycaemic control in Type 2 diabetic patients inadequately controlled by sulphonylurea therapy alone von Buysschaert, M., Bobbioni, E., Starkie, M., Frith, L., Group, For The Troglitazone Study

Volltext

Effects of troglitazone in patients with type 2 diabetes mellitus not adequately controlled by sulfonylureas von Bunnag, Pongamorn, Puavilai, Gobchai, Chanprasertyotin, Suwannee, Chandraprasert, Sunitaya, Suwanwalaikorn, Sompong, Suthijumroon, Ampha, Benjasuratwong, Yupin, Boonyavaraku, Apasanee, Nitiyanant, Wannee, Sriussadaporn, Sutin, Deerochanawong, Chaichan

Volltext

Erratum to: Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients von Kumar, S., Boulton, A. J. M., Beck-Nielsen, H., Berthezene, F., Muggeo, M., Persson, B., Spinas, G. A., Donoghue, S., Lettis, S., Stewart-Long, P.

Volltext

Double-masked, placebo-controlled, dose-ranging study of troglitazone 10 to 200 mg once daily in non—insulin-dependent diabetes mellitus von Leutenegger, Marc, Sacca, Luigi, Alderton, Claire, Eckland, David, Lettis, Sally

Volltext

Effect of Troglitazone in Insulin-Treated Patients with Type II Diabetes Mellitus von Schwartz, Sherwyn, Raskin, Philip, Fonseca, Vivian, Graveline, Jane F

Volltext